• Skip to main content

Hearing Loss Treatment Report

www.HearingLossTreatmentReport.com

AK-OTOF

Akouos Raises $105 Million in Funding to Advance First-In-Human Clinical Studies of AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing Loss

March 3, 2020

https://www.businesswire.com/news/home/20200303005317/en/Akouos-Closes-105-Million-Series-Financing

Precision Genetic Medicine Company Akouos Secures $105 Million In Funding

Akouos Raises $105 Million in Funding to Advance First-In-Human Clinical Studies of AK-OTOF, a Potential Gene Therapy for Sensorineural Hearing Loss

Powered by Urgent Research

Copyright © 2025 Urgent Research